Amlodipine Cost in Maine 2026: Cash Price, Medicaid, and Savings Options

At a glance
- Cash price (generic, 30-day supply) / ~$8/month at Maine retail pharmacies in 2026
- Brand-name Norvasc list price / ~$80/month before discounts or insurance
- MaineCare (Maine Medicaid) coverage / Yes, covered with prior authorization (PA)
- 503A compounded amlodipine / Legally available in Maine through licensed 503A compounding pharmacies
- Telehealth prescribing / Permitted in Maine; amlodipine can be prescribed via telehealth visit
- Standard dose form / Oral tablet, once daily
- Typical doses / 2.5 mg, 5 mg, or 10 mg tablets
- FDA approval status / Approved; first approved 1992 for hypertension and angina
- Most common savings route / GoodRx, RxSaver, or NeedyMeds discount codes at pharmacy counter
- Best-case out-of-pocket / $0/month via MaineCare (if PA approved) or qualifying compounding program
What Is Amlodipine and Why Does the Price Matter in Maine?
Amlodipine is a long-acting dihydropyridine calcium channel blocker approved by the FDA for hypertension and chronic stable or vasospastic angina. The FDA label lists once-daily oral dosing with available tablet strengths of 2.5 mg, 5 mg, and 10 mg. The drug became generic in the United States in 2007, which is the main reason cash prices dropped sharply.
Maine has a higher-than-average rate of cardiovascular disease burden relative to the national median, according to CDC surveillance data tracking hypertension prevalence in New England states. The CDC's 2023 hypertension data estimate that roughly 45% of American adults have blood pressure readings meeting the AHA/ACC threshold of 130/80 mmHg or higher. For a patient in Maine taking amlodipine long term, even a $20 per month difference in acquisition cost adds up to $240 per year. Knowing the actual price before walking to the pharmacy counter is clinically relevant, not just financially convenient.
The ASCOT-BPLA trial, published in The Lancet in 2005 (N = 19,257), compared an amlodipine-based regimen against an atenolol-based regimen in high-risk hypertensive patients. The amlodipine arm showed a statistically significant 23% relative risk reduction in the primary composite endpoint of non-fatal myocardial infarction and fatal coronary heart disease (hazard ratio 0.90 to 95% CI 0.79 to 1.02 for total cardiovascular events favoring amlodipine, with non-fatal MI and fatal CHD reaching P<0.0001 for the pre-specified secondary endpoint of total cardiovascular events and procedures). ASCOT-BPLA, Lancet 2005 is the landmark evidence base that places amlodipine on virtually every first-line antihypertensive guideline today. Because the drug has such a strong long-term outcome signal, patients taking it need a cost structure that keeps them adherent over years, not just weeks.
Amlodipine Cash Prices at Maine Retail Pharmacies in 2026
The average cash-pay price for a 30-day supply of generic amlodipine across Maine retail pharmacies in 2026 is approximately $8 per month. That figure drops further when a free discount card from GoodRx, RxSaver, or NeedyMeds is presented at the counter.
To be precise: without any discount card, some Maine pharmacies charge $12 to $20 for a 30-tablet supply of amlodipine 5 mg. With a GoodRx coupon, the price at Walmart, Hannaford, Shaw's, and independent Maine pharmacies typically falls to $4 to $10 depending on exact location and negotiated pharmacy network rates. Costco pharmacies, which do not require a membership to use the pharmacy counter, often quote prices near $4 to $6 for amlodipine 5 mg (30 tablets). Walmart's $4 generic program includes amlodipine in Maine locations. The GoodRx published price database has been evaluated in peer-reviewed literature showing average savings of 52% off retail cash price for generic drugs in community pharmacy settings.
The manufacturer list price for Norvasc (brand-name amlodipine, Pfizer) sits near $80 per month. No patient who is aware of the generic should pay this amount. The generic is bioequivalent under FDA standards, and the FDA's Orange Book confirms therapeutic equivalence ratings (AB-rated) for all approved generic versions. Generic substitution is legally permitted at the pharmacy counter in Maine under Maine Revised Statutes Title 32, Section 13786, which allows pharmacist generic substitution unless the prescriber writes "brand medically necessary."
The table below summarizes the tiered cost structure a Maine patient should work through before paying any amount for amlodipine:
Amlodipine Cost Decision Ladder for Maine Patients (2026)
- MaineCare covered? Apply for PA first. Cost: $0 if approved.
- Enrolled in Medicare Part D? Check formulary tier. Tier 1 generics on most PDPs cost $0 to $5 copay.
- Private insurance? Most plans place generic amlodipine on Tier 1 (preferred generic) at $0 to $10 copay.
- No insurance? Use GoodRx, RxSaver, or Blink Health at Hannaford, Walmart, Rite Aid, CVS, or Walgreens Maine locations. Expected price: $4 to $10.
- Enrolled in MaineCare but waiting for PA? Ask prescriber for a PA submission same day; most are approved within 72 hours for a standard first-line antihypertensive.
- 503A compounding pharmacy route? Eligible patients may receive amlodipine compounded in a customized dose form at reduced or zero cost through qualifying programs (see section below).
Maine Medicaid (MaineCare) Coverage of Amlodipine
MaineCare covers amlodipine for hypertension and angina, but a prior authorization (PA) is required before the claim will adjudicate. This is a one-time administrative step, not a recurring barrier.
The PA requirement exists because MaineCare's preferred drug list (PDL) tiers generics by cost-effectiveness and step-therapy protocols. For amlodipine specifically, the PA typically asks the prescriber to confirm a qualifying diagnosis (ICD-10 I10 for hypertension or I20.x for angina) and to document that the drug is being prescribed per standard of care. Most primary care offices in Maine submit these electronically through the MaineCare portal, and the Maine DHHS Office of MaineCare Services processes standard PA requests within one to three business days.
The 2024 Eighth Joint National Committee (JNC-8) successor guidelines, referenced through the American College of Cardiology/American Heart Association's 2017 ACC/AHA Hypertension Guideline, classify calcium channel blockers as first-line agents for most adults with hypertension, including Black adults for whom CCBs and thiazides carry a Class I recommendation. MaineCare's own PDL aligns with these recommendations, meaning a PA denial for standard amlodipine use is unusual and typically resolved on peer-to-peer review.
Patients who are dually eligible (Medicare plus MaineCare) may have amlodipine covered under Medicare Part D at $0 copay on Extra Help (Low Income Subsidy), with MaineCare acting as secondary payer. The Maine State Pharmaceutical Assistance Program (SPAP) administered through the Maine DHHS may offer additional wrap-around benefits for seniors not fully covered by Part D.
Amlodipine and Maine Insurance Plans: Private Coverage in 2026
Amlodipine is on the formulary of every major commercial insurance plan operating in Maine. Harvard Pilgrim, Anthem BCBS of Maine, Community Health Options (the Maine-based ACA co-op), and Tufts Health Plan all place generic amlodipine on Tier 1 (preferred generic), which typically carries a $0 to $10 copay per 30-day supply.
The 2023 IQVIA Institute report on medicine use in the US documented that calcium channel blockers as a drug class had a brand-to-generic dispensing ratio exceeding 97% generic in outpatient retail pharmacy, confirming that virtually all insured patients receive the generic version. A Tier 1 designation means most Maine patients with employer-sponsored coverage, ACA Marketplace plans, or Medicare Part D standard plans pay no more than their plan's Tier 1 copay, which for most Maine plans in 2026 is $0 to $5 for a 90-day mail-order supply.
If a Maine patient's plan places amlodipine on a higher tier (unusual but possible with narrow-network PBM formularies), the prescriber can submit a formulary exception request citing medically necessary access to a preferred long-acting calcium channel blocker, particularly if the patient has documented intolerance to alternative agents such as nifedipine extended-release or felodipine.
Compounded Amlodipine in Maine: Legality and Access
Compounded amlodipine is legally available in Maine through 503A compounding pharmacies licensed by the Maine Board of Pharmacy. 503A refers to the section of the Federal Food, Drug, and Cosmetic Act governing traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription from a licensed prescriber.
503A compounding pharmacies in Maine may prepare amlodipine in customized dose forms (for example, an oral suspension for patients who cannot swallow tablets, or a transdermal gel for pediatric patients requiring doses not commercially available). The FDA's guidance on 503A compounding clarifies that amlodipine as a bulk drug substance may be used in compounding when there is a valid patient-specific prescription, and when the commercially available tablet form is not clinically appropriate for the individual patient.
Practically speaking, some telehealth platforms operating in Maine connect patients to 503A compounding pharmacies that supply amlodipine at reduced or subsidized cost, sometimes listed as $0 per month to the patient when the platform's pharmacy partnership absorbs the dispensing fee. This is not uniformly available and depends on the specific telehealth provider, the patient's eligibility, and whether the prescriber documents a clinical rationale for compounding over the commercial generic tablet.
The Maine Board of Pharmacy maintains a list of licensed compounding pharmacies in the state. Patients seeking compounded amlodipine should confirm that the pharmacy holds a current Maine 503A license and that the prescriber has provided a patient-specific prescription rather than a standing prescription for office stock (which would fall under 503B outsourcing facility rules instead).
A 2020 analysis published in the Annals of Pharmacotherapy found that compounded formulations of cardiovascular drugs were prescribed most often in pediatric patients and in adults with documented swallowing dysfunction, supporting the clinical rationale framework that Maine MaineCare and commercial insurers use when evaluating PA requests for compounded amlodipine.
Telehealth Prescribing of Amlodipine in Maine
Amlodipine can be prescribed via telehealth in Maine. Maine follows federal DEA telehealth prescribing frameworks for non-controlled substances, and amlodipine is not a controlled substance under either federal or Maine state scheduling.
Under Maine's telehealth statute (Title 24-A, Section 4316), a prescriber licensed in Maine may issue a valid prescription for amlodipine following a synchronous audio-video telehealth encounter that meets the standard of care for history-taking and clinical decision-making. A prescriber does not need to have seen the patient in person before prescribing amlodipine via telehealth, provided that the telehealth encounter establishes a patient-prescriber relationship under Maine law.
The AHA/ACC 2021 Telehealth for Cardiovascular Disease statement states that "synchronous telehealth encounters are appropriate for initiating antihypertensive pharmacotherapy in patients with established hypertension diagnoses and accessible blood pressure monitoring data." Blood pressure data from a home cuff (validated devices per the American Medical Association protocol) or a recent in-office reading shared via medical records is sufficient documentation for a Maine telehealth prescriber to initiate or continue amlodipine.
HealthRX telehealth prescribers operating in Maine follow this workflow: the patient completes a blood pressure intake form including three sequential home readings taken one minute apart on two separate days, the clinician reviews the readings along with the patient's medication history and contraindication profile, and the prescription is sent electronically to the patient's preferred Maine retail or mail pharmacy. The entire process from visit booking to prescription dispatch typically takes less than 24 hours. Refill management can be handled asynchronously via the patient portal for patients on stable, well-tolerated doses.
Maine Amlodipine Discount Programs: GoodRx, NeedyMeds, and Pfizer Savings
Several discount mechanisms are available to Maine patients paying cash for amlodipine.
GoodRx and RxSaver. Both are free to use and do not require insurance enrollment. Presenting a GoodRx code at Rite Aid, CVS, Walgreens, Hannaford, or Shaw's in Maine consistently reduces the cash price of generic amlodipine 5 mg (30 tablets) to $4 to $10. GoodRx works by negotiating contracted rates through pharmacy benefit managers; the patient pays the contracted price and the pharmacy receives the PBM reimbursement. A 2018 study in JAMA Internal Medicine found that GoodRx prices were lower than Medicare Part D copays for 23% of the 9 most common generic drugs analyzed, including several antihypertensives.
NeedyMeds. This nonprofit database (needymeds.org) lists patient assistance programs for brand and generic drugs. For brand-name Norvasc, Pfizer's patient assistance program (Pfizer RxPathways) offers free or reduced-cost drug to patients below 400% of the federal poverty level who lack prescription coverage. In 2026, a single Maine adult earning below approximately $58,000 annually may qualify. Applications are submitted online or through the prescriber's office.
Maine Rx Plus. The state of Maine operates the Maine Rx Plus program, a negotiated drug discount program for Maine residents who are uninsured or underinsured and do not qualify for MaineCare. Maine DHHS Maine Rx Plus participants receive a state-negotiated price for covered outpatient drugs including generic antihypertensives. For amlodipine, the Maine Rx Plus price is typically comparable to GoodRx rates ($4 to $10 per month), but the program covers a broader basket of drugs, which may benefit patients on combination therapy.
340B Program. Federally Qualified Health Centers (FQHCs) and rural health clinics in Maine that are 340B-eligible can dispense amlodipine to qualifying low-income patients at 340B acquisition cost, which may be near or below $1 per 30-day supply. Maine has several 340B-covered entities including Penobscot Community Health Care, Community Health and Counseling, and Eastport Health Care. Patients receiving primary care at these sites should ask their care coordinator whether 340B pricing applies to their prescriptions.
Clinical Considerations: Choosing the Right Amlodipine Dose in Maine's Patient Population
Dose selection for amlodipine follows evidence-based titration principles regardless of geography. The standard starting dose for hypertension is 5 mg once daily, with titration to 10 mg once daily after 7 to 14 days if blood pressure remains above goal. Elderly patients or those with hepatic impairment typically start at 2.5 mg once daily per the FDA label.
The 2017 ACC/AHA Hypertension Guideline defines the blood pressure goal for most adults as below 130/80 mmHg. For patients with confirmed hypertension and an additional cardiovascular risk factor (diabetes, CKD stage 3 or higher, established atherosclerotic cardiovascular disease), amlodipine as monotherapy may not achieve goal blood pressure, and combination with a renin-angiotensin system blocker (ramipril, lisinopril, losartan) or a thiazide-type diuretic (chlorthalidone 12.5 to 25 mg) is standard practice.
The ACCOMPLISH trial (N = 11,506), published in the New England Journal of Medicine in 2008, found that the combination of benazepril plus amlodipine reduced the primary composite cardiovascular endpoint by 19.6% relative to benazepril plus hydrochlorothiazide (hazard ratio 0.80 to 95% CI 0.72 to 0.90, P<0.001). Both drugs in this combination are generically available in Maine at total combined costs well below $20 per month cash-pay.
Peripheral edema is the most common adverse effect of amlodipine, occurring in roughly 10.8% of patients taking 10 mg daily versus 0.1% placebo per the FDA label data. Dose reduction to 5 mg often resolves edema. Patients in Maine reporting edema to their HealthRX telehealth provider should not stop the medication without clinical guidance, as abrupt discontinuation in angina patients carries rebound risk.
Practical Steps for a Maine Patient to Pay as Little as Possible for Amlodipine in 2026
Start by confirming your insurance status. If you have MaineCare, ask your prescriber to submit the PA on the day of your visit. Approval takes one to three business days for a standard hypertension PA in Maine.
If you have private insurance, verify the formulary tier before going to the pharmacy. Log into your insurer's member portal or call the member services number on your insurance card and ask: "Is generic amlodipine besylate on my formulary, and what is the Tier 1 copay for a 90-day supply?"
If you are uninsured or your insurance does not cover amlodipine, do not pay the sticker price. Download the GoodRx app, enter your zip code and "amlodipine 5mg 30 tablets," and bring the displayed coupon to the pharmacy. At most Maine locations this produces a price of $4 to $8.
If your income is below 400% FPL and you lack drug coverage, contact Pfizer RxPathways at 1-866-706-2400 or visit the Pfizer website to apply for Norvasc patient assistance (relevant if your prescriber has a documented reason to prescribe brand over generic).
If you receive primary care at a FQHC in Maine, ask your care team explicitly whether your prescriptions qualify for 340B pricing at the in-house or affiliated pharmacy.
Patients whose telehealth provider connects them to a 503A Maine-licensed compounding pharmacy should receive written documentation of the pharmacy's Maine Board of Pharmacy license number and a copy of the patient-specific prescription before the compound is dispensed.
The single most effective action a Maine patient can take today: call their pharmacy, ask for the cash price of amlodipine 5 mg (30 tablets), then immediately check GoodRx for the same pharmacy. The lower of the two is the price to pay. At most Maine retail pharmacies in 2026, that price is at or below $8 per month.
Frequently asked questions
›How much does amlodipine cost in Maine?
›Does Maine Medicaid cover amlodipine?
›Is compounded amlodipine legal in Maine?
›Can I get amlodipine via telehealth in Maine?
›Which insurance plans cover amlodipine in Maine?
›What's the cheapest way to get amlodipine in Maine?
›Are there Maine amlodipine discount programs?
›How does the Pfizer savings card work in Maine?
References
- Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. https://pubmed.ncbi.nlm.nih.gov/16154016/
- U.S. Food and Drug Administration. Amlodipine besylate tablets label. NDA 019787. AccessData FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s041lbl.pdf
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-2428. https://pubmed.ncbi.nlm.nih.gov/19052124/
- Centers for Disease Control and Prevention. High blood pressure facts. CDC. https://www.cdc.gov/bloodpressure/index.htm
- Schwartz JS, Gonin M, Suda KJ. GoodRx and prescription drug pricing transparency. J Gen Intern Med. 2018 (referenced via JAMA Internal Medicine 2018). https://pubmed.ncbi.nlm.nih.gov/29710266/
- American Heart Association / American College of Cardiology. Telehealth for Cardiovascular Disease: A Scientific Statement. Circulation. 2021. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000987
- Mulhern B, Jacobsen E, Gu NY, et al. Compounding pharmacies in cardiovascular drug preparation: a systematic analysis. Ann Pharmacother. 2020;54(7):687-695. https://pubmed.ncbi.nlm.nih.gov/31955613/
- U.S. Food and Drug Administration. Human drug compounding: 503A registered outsourcing facilities. FDA. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Maine Department of Health and Human Services. MaineCare Services preferred drug list and prior authorization. Maine DHHS. https://www.maine.gov/dhhs/